Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 1647-1652, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curme, H.
Right arrow Articles by Rand, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curme, H.
Right arrow Articles by Rand, R. N.
Related Collections
Right arrow History
(Clinical Chemistry. 1997;43:1647-1652.)
© 1997 American Association for Clinical Chemistry, Inc.


Articles

Early history of Eastman Kodak Ektachem slides and instrumentation

Henry Curme and Royden N. Randa

Both authors are retirees of the Eastman Kodak Co.
a Address correspondence to this author, at: PO Box 252, Pittsford, NY 14534–0252.


   Introduction
 
The Ektachem story starts in 1970 at the Eastman Kodak Co. in Rochester, NY.1 For some time, Eastman Organic Chemicals had supplied reagents to the clinical laboratory. Al Baitsholts, product manager for a thin-layer chromatographic system of impressive analyte sensitivity, became convinced that some kind of thin-layer format might form the basis for a new approach to routine clinical chemistry analysis. His timing was excellent because Kodak was interested in new products that could be made by using proprietary coating technology. Al visited his former boss and friend, Edwin Przybylowicz, a senior manager in the Kodak Research Laboratories. They discussed various configurations of thin-layer chemistry that would require no more than 10 µL of a biological fluid (serum, plasma, whole blood, and even cerebrospinal fluid) and that would yield a quantitative result.

Przybylowicz was strongly taken with some of the suggestions. He formed a team consisting of Charles Warburton, Leo Kunzelsauer, and William Fellows to explore some possibilities. The goal that emerged from these early experiments was to create dry, thin films containing all of the reagents necessary for clinical analysis by colorimetry. Reagents in a matrix of hydrophilic polymer would be coated on top of a transparent plastic base and dried. Upon applying the test sample to the film, water and the analytes would diffuse into the reagent layers, initiating the reaction sequence(s). The extent of reaction would be determined by colorimetry.

Spreading the test sample over the film proved to be a considerable challenge: The fluid tended to form a bead on the surface of the film. The exploratory group initially used filter paper, plastic filters, or woven fabric to spread the fluid over the reagent layer. A better solution was to coat the spreading layer as a slurry of solid particles along with a binding material over . . . [Full Text of this Article]


   Acknowledgments
 

   Footnotes
 

   References
 



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
N. Raby, C. Bonneau, S. Gillier, J. Le, R. Granouillet, J. Frey, and A. Chamson
Single Dilution for Urine Assays on the Vitros 250 or 700 Analyzers
Clin. Chem., August 1, 1998; 44(8): 1746 - 1748.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.